🇮🇩 Country Profile

Indonesia

Fast-growing pharmaceutical trade with Indonesia

🇮🇩 $256M
All data from DGCIS India export records (fiscal year, April–March).
$256M
Scale
Indonesia's healthcare system receives $256M in Indian pharmaceutical products each year — affordable, quality medicine.
42%
Medicine
A diverse pharmaceutical mix: medicine ingredients, vaccines, and medicines each contributing significantly.
4.0×
Trajectory
One of the faster-growing relationships — India's pharmaceutical supply to Indonesia has expanded 4.0× over the decade.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Indonesia — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $108M (42.3%) Vaccines $93.8M (36.7%) Medicines $41.4M (16.2%) Surgical & Hospital Supplies $9.4M (3.7%) Traditional & Herbal $2.8M (1.1%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Indonesia Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Indonesia: $5.0M across 5 filings (2020-2026).